Sjukvård | Njur | Dialys - Fresenius Medical Care

24
Acute Therapy Systems Product Range

Transcript of Sjukvård | Njur | Dialys - Fresenius Medical Care

Page 1: Sjukvård | Njur | Dialys - Fresenius Medical Care

Acute Therapy Systems

Product Range

Page 2: Sjukvård | Njur | Dialys - Fresenius Medical Care

Continuous renal replacement therapy Multifunctional and easy to use

Fresenius Medical Care has always focused on

services for people.

We concentrate on the patients’ health as well as

the staff in the clinics.

In this brochure you will find a comprehensive

product range for acute renal replacement and

plasma therapy. These disposables and solutions

from Fresenius Medical Care have been specially

developed for the use in life-threatening situations.

In combination with the multiFiltrate the disposables

and solutions provide effective and safe treatments for

patients. The products are specially designed to com-

plement each other. As a result this enables nursing staff

to focus on patient care. In this brochure you will find

a number of benefits for patients, doctors and nurses.

Acute renal replacement therapy with

Fresenius Medical Care:

• Reliable

• Convenient

• Effective

Page 3: Sjukvård | Njur | Dialys - Fresenius Medical Care

3Technical changes reserved Product Range – 01. 2010

Contents

multiFiltrate acute therapy system ......................................................... 4

Complete kits for multiFiltrate ................................................................ 6

multiFiltrate: paediatric CRRT and SCUF ........................................... 10

CRRT haemofilters ............................................................................ 12

Plasmafilters ...................................................................................... 13

Solutions ........................................................................................... 14

Temporary dialysis catheters .............................................................. 20

Disposables and accessories ............................................................. 21

Page 4: Sjukvård | Njur | Dialys - Fresenius Medical Care

4 Product Range – 01. 2010 Technical changes reserved

multiFiltrateAcute therapy system

The setup of the tubing systems is clearly shown and

explained step by step on the screen of the multiFiltrate

Multifunctional and easy to use

Safe and easy handling is one of the main requirements

for a modern, multifunctional acute therapy system.

The multiFiltrate features an ergonomical and intuitive

operating concept with a wide range of renal replace-

ment therapies.

multiFiltrate acute therapy machine:

multiFiltrate basic Art. No. M20 070 1

with Ci-Ca module Art.-Nr. M20 127 1

Page 5: Sjukvård | Njur | Dialys - Fresenius Medical Care

5Technical changes reserved Product Range – 01. 2010

CVVHContinuous veno-venous haemofiltration

CVVHDContinuous veno-venous haemodialysis

CVVHDFContinuous veno-venous haemodiafiltration

Pre-Post CVVHPre-post continuous veno-venous haemofiltration (High volume)

paed CVVHPaediatric continuous veno-venous haemofiltration

paed CVVHDPaediatric continuous veno-venous haemodialysis

SCUFSlow continuous ultrafiltration

Range of therapies offered by the multiFiltrate acute therapy system

MPSMembrane plasma separation

HPHemoperfusion

Ci-Ca CVVHDContinuous veno-venous haemodialysis with citrate anticoagulation

Page 6: Sjukvård | Njur | Dialys - Fresenius Medical Care

6 Product Range – 01. 2010 Technical changes reserved

Complete kits for multiFiltrate

The multiFiltrate cassette – safe and easy

The multiFiltrate cassette consists of the arterial, venous

and filtrate lines. This allows easy installation of the tub-

ing systems required for each treatment. The combina-

tion of the multiFiltrate cassette with treatment specific

tubing systems enables the multiFiltrate to be set up

quickly, safely and easily.

multiFiltrate-Kit

The multiFiltrate-Kits contain:

• multiFiltrate cassette

(AV-set and filtrate system pre-assembled)

• Substituate and/or dialysate system

(depends on therapy modality)

• Haemofilter or plasmafilter

Kit guideline chart SCUF CVVH Pre-PostCVVH CVVHDF CVVHD Ci-CaCVVHD MPS HP paedCVVH paedCVVHD

5039011 multiFiltrateKitCi-CaCVVHD1000

5038871 multiFiltrateKit8CVVHDF1000

5038931 multiFiltrateKit4CVVHDF600

5038921 multiFiltrateKit3CVVHD600

5038181 multiFiltrateKit7HV-CVVH1000

5038791 multiFiltrateKit9CVVH1000

5038911 multiFiltrateKit2CVVH600

5038951 multiFiltrateKit6MPS2

5039051 multiFiltrateKitpaedCRRT/SCUF

= Dedicated usage, = Alternative usage

Page 7: Sjukvård | Njur | Dialys - Fresenius Medical Care

7Technical changes reserved Product Range – 01. 2010

Ci-Ca CVVHDContinuousveno-venoushaemo-dialysiswithcitrateanticoagulation

multiFiltrate – Kit Ci-Ca CVVHD 1000 Art. No. 503 901 1

Type Description

Ultraflux® AV 1000 S Ultraflux haemofilter, steam-sterilised, surface area 1.8 m2,

Fresenius High-Flux Polysulfone® membrane

multiFiltrate Ci-Ca Cassette multiFiltrate cassette with arterial and venous blood

tubing systems, filtrate system and integrated citrate

and calcium lines

Dialysate system Dialysate system for multiFiltrate with integrated

multiFiltrate heater bag

CVVHDFContinuousveno-venoushaemodiafiltration

multiFiltrate – Kit 8 CVVHDF 1000 Art. No. 503 887 1

Type Description

Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface

area, Fresenius Polysulfone® membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

Substituate System Substituate system for multiFiltrate with integrated

multiFiltrate heater bag

Dialysate System Dialysate system for multiFiltrate with integrated

multiFiltrate heater bag

multiFiltrate – Kit 4 CVVHDF 600 Art. No. 503 893 1

Type Description

Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface

area, Fresenius Polysulfone® membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

Substituate System Substituate system for multiFiltrate with integrated

multiFiltrate heater bag

Dialysate System Dialysate system for multiFiltrate with integrated

multiFiltrate heater bag

Page 8: Sjukvård | Njur | Dialys - Fresenius Medical Care

8 Product Range – 01. 2010 Technical changes reserved

Complete kits for multiFiltrate

CVVHDContinuousveno-venoushaemodialysis

multiFiltrate – Kit 3 CVVHD 600 Art. No. 503 892 1

Type Description

Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface

area, Fresenius Polysulfone® membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

Dialysate System Dialysate system for multiFiltrate with integrated

multiFiltrate heater bag

Pre-Post CVVHPre-postcontinuousveno-venoushaemofiltration(Highvolume)

multiFiltrate – Kit 7 HV-CVVH 1000 (High-Volume CVVH) Art. No. 503 818 1

Type Description

Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface

area, Fresenius Polysulfone® membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

HV-CVVH Substituate 2 substituate lines for multiFiltrate with integrated heater

Set multiFiltrate bags for pre- and postdilution

Page 9: Sjukvård | Njur | Dialys - Fresenius Medical Care

9Technical changes reserved Product Range – 01. 2010

multiFiltrate – Kit 6 MPS 2 (Membrane Plasma Separation) Art. No. 503 895 1

Type Description

plasmaFlux PSu 2S Plasmafilter pre-filled with sterile water, steam-sterilised

0.6 m2 surface area, Fresenius Plasmasulfone membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

MPS Substituate Substituate System for multiFiltrate with 2 integrated

System multiFiltrate heater bags, Luer-Lock male with 4 vented Spikes

pre-connected

Filtrate collection bag Filtrate collection bag, 10 L, with draining cock,

Luer-Lock connector male

MPSMembraneplasmaseparation

CVVHContinuousveno-venoushaemofiltration

multiFiltrate – Kit 9 CVVH 1000 Art. No. 503 879 1

Type Description

Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface

area, Fresenius Polysulfone® membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

Substituate System Substituate system for multiFiltrate with integrated

multiFiltrate heater bag

multiFiltrate – Kit 2 CVVH 600 Art. No. 503 891 1

Type Description

Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface

area, Fresenius Polysulfone® membrane

multiFiltrate cassette Pre-assembled multiFiltrate cassette with arterial,

venous and filtrate system

Substituate System Substituate system for multiFiltrate with integrated

multiFiltrate heater bag

Page 10: Sjukvård | Njur | Dialys - Fresenius Medical Care

10 Product Range – 01. 2010 Technical changes reserved

multiFiltrate: paediatric CRRT and SCUFSafe and efficient treatment of babies, infants and adults

A specifically developed multiFiltrate treatment-mode monitors the paediatric

therapy. The Ultraflux® AV paed haemofilter combined with special volume-

reduced lines is used to perform paediatric CVVH in post- or predilution

and CVVHD.

multiFiltrate Kit paed CRRT/SCUFmultiFiltrate – Kit paed CRRT/SCUF Art.-Nr. 503 905 1

Type Description

multiFiltrate paed AV-Set paed, blood volume 54 mL, filtrate system and

CRRT/SCUF Set dialysate/substituate system packed as a set

Ultraflux® AV paed Ultraflux® haemofilter, steam-sterilised,

surface area 0.2 m2 Fresenius High-Flux Polysulfone® membrane

Ultraflux® AV paed can only be used with holder for small dialysers (Art. No. M38 420 1) Total extracorporeal blood volume is only 72 mL (AV-Set 54 mL; Filter 18 mL)

Treatment parameters for paediatric treatment

Parameters

min. max. Increments Unit

Blood flow 10 100 2 mL/min

Ultrafiltration Off / 5 500 5 mL/h

UF goal Off /10 5000 10 mL

Cont. heparin adm. Off / 0.1 25 0.1 mL/h

Dialysate 100 1500 10 mL/h

Temperature Off / 35 39 0.5 °C

paed CVVHPaediatriccontinuousveno-venoushaemofiltration

paed CVVHDPaediatriccontinuousveno-venoushaemodialysis

Page 11: Sjukvård | Njur | Dialys - Fresenius Medical Care

11Technical changes reserved Product Range – 01. 2010

multiFiltrate Kit paed CRRT/SCUFmultiFiltrate – Kit paed CRRT/SCUF Art.-Nr. 503 905 1

Type Description

multiFiltrate paed AV-Set paed, blood volume 54 mL, filtrate system and

CRRT/SCUF Set dialysate/substituate system packed as a set

Ultraflux® AV paed Ultraflux® haemofilter, steam-sterilised,

surface area 0.2 m2 Fresenius High-Flux Polysulfone® membrane

Ultraflux® AV paed can only be used with holder for small dialysers (Art. No. M38 420 1) Total extracorporeal blood volume is only 72 mL (AV-Set 54 mL; Filter 18 mL)

The combination of the Ultraflux® AV paed haemofilter and the volume-

reduced lines enables the user to perform an efficient continuous ultrafil-

tration for adult and paediatric patients.

Treatment parameters for SCUF treatment

Parameters

min. max. Increments Unit

Blood flow 10 100 2 mL/min

Ultrafiltration Off / 10 1200 10 mL/h

UF goal Off /50 10000 50 mL

Cont. heparin adm. Off / 0.1 25 0.1 mL/h

SCUFSlowcontinuousultrafiltration

Page 12: Sjukvård | Njur | Dialys - Fresenius Medical Care

12 Product Range – 01. 2010 Technical changes reserved

CRRT haemofiltersUltraflux® series

Ultraflux® filters contain a Fresenius Polysulfone®

membrane specifically developed for continuous

renal replacement therapy. Successful treatments

are achieved by:

• Filter characteristics similar to those of the human

kidney’s glomeruli

Haemofilters

Type Description Units per box Art. No.

Ultraflux® AV 400 S Ultraflux® haemofilter, steam-sterilised, 0.75 m2 surface area, 12 500 734 1

Fresenius Polysulfone® membrane, blood priming volume 52 mL

Ultraflux® AV 600 S Ultraflux® haemofilter, steam-sterilised, 1.4 m2 surface area, 12 500 736 1

Fresenius Polysulfone® membrane, blood priming volume 100 mL

Ultraflux® AV 1000 S Ultraflux® haemofilter, steam-sterilised, 1.8 m2 surface area, 12 500 898 1

Fresenius Polysulfone® membrane, blood priming volume 130 mL

Ultraflux® AV paed Ultraflux® haemofilter, steam-sterilised, 0.2 m2 surface area, 20 500 823 1

Fresenius Polysulfone® membrane, blood priming volume 18 mL

Luer-Lock Dialysate & Filtrate ports

Ultraflux® AV paed must only be used with the dialyser holder for small dialysers (Art. No. M38 420 1)

• Retention of plasma proteins such as albumin, clotting

factors, immunglobulins and cellular blood constituents

• Excellent filter lifetimes

• Easy handling

• High biocompatibility

• Mechanical stability

• Filter size selectable to meet patient’s requirements

Page 13: Sjukvård | Njur | Dialys - Fresenius Medical Care

13Technical changes reserved Product Range – 01. 2010

PlasmafiltersplasmaFlux® series

The hollow fibres of the plasmaFlux® series sepa-

rate cell-free plasma from whole blood in order to

treat patients by plasma exchange or other plasma

therapies. Requirements for successful treatments

are fulfilled by the plasmaFlux® filter characteristics:

Plasmafilters

Type Description Units per box Art. No.

plasmaFlux PSu 1S Plasmafilter pre-filled with sterile water, steam-sterilised, 0.3 m2 surface area, 10 500 491 1

blood priming volume 36 mL, Fresenius Plasmasulfone membrane

plasmaFlux PSu 2S Plasmafilter pre-filled with sterile water, steam-sterilised, 0.6 m2 surface area, 10 500 481 1

blood priming volume 70 mL, Fresenius Plasmasulfone membrane

• Efficient extraction of pathogenic factors

• High biocompatibility

• Easy handling

• Long filter lifetimes

• Low extracellular volume

• Minimum requirement for anticoagulation therapy

Inline steam sterilisation

Filters of the Ultraflux® and plasmaFlux® series are 100% leakage checked and steam-

sterilized to offer a safe product that is free of any residues from the sterilization process.

Page 14: Sjukvård | Njur | Dialys - Fresenius Medical Care

14 Product Range – 01. 2010 Technical changes reserved

SolutionsmultiBic® – bicarbonate-buffered haemofiltration solutions

Larger, quieter, more convenient:When time is of the essence, every convenience helps.

For example, the new multiBic® double chamber bag

with diagonal peel-seam for simpler handling. Thanks

to 11% more content, the new 5 litre multiBic® doesn’t

need to be changed so often – leaving more time for

other tasks. The improved gas barrier helps to keep the

ready-to-use bicarbonate solution stable for longer so

that the infusion of the patient can last up to 48 hours.

The new 5 litre multiBic® at a glance:

• Mixing the two components provides 100% bicarbonate-buffered haemofiltration solution

• Always the right solution thanks to 4 different potassium concentrations

• Fewer bag changes thanks to 11% more content

• Increased solution stability, usable for up to 48 hrs. thanks to the improved gas barrier

• Simpler handling thanks to the bag geometry with diagonal peel-seam

• PVC, latex and DEHP-free, environmentally friendly thanks to use of “Biofine” material

• Quieter thanks to the packaging’s softer, sound-reduced foil

• Improved monitoring through the clear, transparent foil

• Easier transport thanks to the new, comfortable handle

• Suitable for almost all common CRRT appliances thanks to the bag eyelets and connectors

• Addition of medication possible thanks to the injection port

Page 15: Sjukvård | Njur | Dialys - Fresenius Medical Care

15Technical changes reserved Product Range – 01. 2010

Excipients: Water for injections, hydrochloric acid (25%), carbon dioxide

Indications: For use in patients with acute renal failure requiring continuous haemofiltration.

Contraindications: Solution dependent contraindications:

multiBic® potassium-free/2/3 mmol/L potassium:– hypokalaemia – metabolic alkalosis

multiBic® 4 mmol/L potassium:– hyperkalaemia – metabolic alkalosis

Haemofiltration dependent contraindications due to the technical procedure itself: – Renal failure with increased hypercatabolism in cases where uraemic symp-

toms can no longer be relieved by haemofiltration.– Inadequate blood flow from vascular access.– If there is a high risk of haemorrhage on account of systemic anticoagulation.

Side effects: Adverse reactions, such as nausea, vomiting, muscle cramps, hypotension and hypertension, may result from the treatment mode itself or may be induced by the substitution solution.

In general, the tolerability of bicarbonate buffered haemofiltration solution is good. However, the following potential side effects of the treatment can be anticipated:

Hyper- or hypohydration, electrolyte disturbances (e. g. hypokalaemia), hypo-phosphataemia, hyperglycaemia, and metabolic alkalosis.

Warnings and Precautions: Do not use unless solution is clear and the container is undamaged. Do not use before the two solutions have been mixed. The ready-to-use solution must be used within 48 hours after mixing. Any unused residual solution should be discarded. Do not store below +4°C.

Date: November 2009Fresenius Medical Care Deutschland GmbH 61346 Bad Homburg v.d.H., Germany

multiBic® potassium-free, Solution for HaemofiltrationmultiBic® 2 mmol/L potassium, Solution for HaemofiltrationmultiBic® 3 mmol/L potassium, Solution for HaemofiltrationmultiBic® 4 mmol/L potassium, Solution for Haemofiltration

multiBic® potassium-free/2/3/4 mmol/L potassium is delivered in a double-chamber bag. One chamber (large compartment) contains the alkaline hydrogen carbonate solution, the other chamber (small compartment) contains the acidic glucose-based electrolyte solution. Mixing of both solutions by opening the peel-seam between the two chambers results in the ready-to-use solution.

Composition: 1000 mL of the ready-to-use solution contain in mmol/L

Name Theoret. Na+ K+ Ca++ Mg++ CI– HCO3

– Glucose Osmol.multiBic® mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mosm/L

potassium-free 140 – 1.5 0.50 109 35 5.55 292

2 mmol/L potassium 140 2.0 1.5 0.50 111 35 5.55 296

3 mmol/L potassium 140 3.0 1.5 0.50 112 35 5.55 298

4 mmol/L potassium 140 4.0 1.5 0.50 113 35 5.55 300

pH 7.40 Availability depending on pharmaceutical product registration.

Composition: 1000 mL of the ready-to-use solution contain in g/L

Name Sodium Calcium Magnesium Glucose Sodium Potassium hydrogen chloride chloride mono- EquivalentmultiBic® chloride chloride carbonate dihydrate hexahydrate hydrate to glucose

potassium-free 6.136 – 2.940 0.2205 0.1017 1.100 1.000

2 mmol/L potassium 6.136 0.1491 2.940 0.2205 0.1017 1.100 1.000

3 mmol/L potassium 6.136 0.2237 2.940 0.2205 0.1017 1.100 1.000

4 mmol/L potassium 6.136 0.2982 2.940 0.2205 0.1017 1.100 1.000

Order information Language/Art. No.

Name D/NL/F/I GB/P/S/FIN E/TR/CZ/HU EST/LV/SK GB/HR/BiH RUS/UA DK/N PL/LT SLO/GR RO multiBic® 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L 2 × 5 L

potassium-free 967 820 1 F00 001 138 F00 001 142 F00 001 146 F00 001 134 F00 001 300

2 mmol/L potassium 967 920 1 F00 001 139 F00 001 143 F00 001 147 F00 001 135 F00 001 301

3 mmol/L potassium 967 220 1 F00 001 140 F00 001 144 F00 001 148 F00 001 136 F00 001 302

4 mmol/L potassium 967 320 1 F00 001 141 F00 001 145 F00 001 149 F00 001 137 F00 001 303

Packaging: 5 litre bag, 2 bags per box, 104 bags per pallet

Page 16: Sjukvård | Njur | Dialys - Fresenius Medical Care

16 Product Range – 01. 2010 Technical changes reserved

SolutionsCi-Ca Solutions

Citrate anticoagulation for CRRT – A beneficial system:

• clearly reduced risk of bleeding

• prolonged filter life-spans

• Successful treatments of patients with HIT II

The advantage of the Ci-Ca method is that it acts exclu-

sively in the extracorporeal circuit making this method

specifically attractive for intensive care patients and

patients at risk of bleeding.

Ci-Ca Dialysate K2 and Ci-Ca Dialysate K4

The major role in regional citrate anticoagulation is

assigned to the calcium-free Ci-Ca Dialysate.

• two different potassium concentrations allow the

adaption to the patient´s requirements

• 5 L double chamber bag for safe and convenient

handling

• use of the mixed solutions for up to 48 h

Page 17: Sjukvård | Njur | Dialys - Fresenius Medical Care

17Technical changes reserved Product Range – 01. 2010

Article Art. no. Composition of the solution

Citrate mmol/L

4% Na3 citrate E2011 136

Packaging: 1 litre bag, 7 bags/box pH adjustment with citric acid

Article Art. no. Composition of the solution

Na+ K+ Ca++ Mg++ Cl– HCO3– Glucose

mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L g/L

Ci-Ca Dialysate K2 968 920 1 133 2.0 0 0.75 116.5 20 1.0

Ci-Ca Dialysate K4 F00 000 431 133 4.0 0 0.75 118.5 20 1.0

Packaging: 5 litre bag Other constituents: water for injections, hydrochloric acid 25%, carbon dioxide

2 bags per box

Ci-Ca Dialysate

Sodium Citrate 4%

Citrate solution for Ci-Ca therapy

The citrate solution refrains coagulation by forming

chelate complexes with the ionised calcium in blood.

• 4% citrate solution and Ci-Ca Dialysate are adapt-

ed to each other

• The citrate bag is equipped with a special

connector to avoid misconnections

Saline solutions

Type Art. no. Presentation Units per box Units per pallet

Isotonic saline solutions 0.9% 131 067 1 30 × 250 mL 1,440 units

(1 litre contains sodium chloride 9.0 g, 131 865 1 15 × 500 mL 720 units

Na+ 154 mmol/L, CI– 154 mmol/L) 131 866 1 10 × 1000 mL 480 units

If products are categorised as pharmaceuticals, availability depending on pharmaceutical product registration.

Sodium Citrate 4%

Page 18: Sjukvård | Njur | Dialys - Fresenius Medical Care

18 Product Range – 01. 2010 Technical changes reserved

SolutionsmultiPlus – The solution with physiological phosphate level

multiPlus

multiPlus (containing 1 mmol/L phosphate) prevents

the depletion of phosphate during CRRT.

• multiPlus prevents the development of hypophos-

phatemia

• Phosphate und glucose ensure the adequate provi-

sion of energy rich components for metabolic proc-

esses and may support the weaning from mechani-

cal ventilation.

Article Art. No. Composition of the solution:

Na+ K+ Ca++ Mg++ Cl– HCO3– Inorganic Phosphate Glucose

mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L g/L

multiPlus 968 820 1 140 2.0 1.5 0.75 109.7 35 1.0 1.0

Packaging: 5 litre bag, Other constituents: water for injection, hydrochloric acid 25%, carbon dioxide

2 bags per box

Page 19: Sjukvård | Njur | Dialys - Fresenius Medical Care

19Technical changes reserved Product Range – 01. 2010

Indications:1. End stage chronic renal disease (decompensation) of all origins2. Acute renal failure not accompanied by hypercatabolism3. Cardiac insufficiency not easily influenced by medicaments and caused by

hyperhydratation4. Acute states of intoxication caused by non-protein-bound poisons; use either

alone or in conjunction with other detoxication measures (haemodialysis, peritoneal dialysis and/or haemoperfusion)

5. Metabolic disturbance resulting from end stage chronic renal failure

Contraindications:Contraindications caused by the treatment:1. Acute renal failure accompanied by marked hypercatabolic conditions in cases

where uraemic symptoms can no longer be relieved by haemofiltration2. Insufficient blood flow from the shunt3. Recent cerebral or internal (parenchymatous) haemorrhages

Contraindications caused by the solution:HF 11: 1. Hypokalaemia 2. Impairment of lactate metabolism/lactate acidosis

HF 12, HF 23, HF 24: 1. Hypokalaemia 2. Hypercalcemia 3. Impairment of lactate metabolism/lactate acidosis

Note:HF 11, HF 12, HF 23: In cases of marked hyperhydration and marked dehydration (high ultrafiltra-tion), it is advisable to use a solution with a higher sodium content, taking into account the serum sodium concentration of the patient.

HF 11, 12: In diabetic patients receiving insulin, the dose of insulin should be adjusted as appropriate for the glucose content of the haemofiltration solution.

Side effects:None have been observed up to the present.

Warnings and precautions:Do not store above +25°C. Do not use unless solution is clear and the con-tainer is undamaged.

Date: November 2009 Fresenius Medical Care Deutschland GmbH,61346 Bad Homburg v.d.H., Germany

Type/Art. No. Composition of the ready-to-use solution in mmol/L:

Name 2 × 2 × Na+ K+ Ca++ Mg++ CI– Lactate – Theoret. Osmol

4.5 L 5.0 L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mosm/L

HF 11 207 659 1 – 140 1 1.625 0.75 100.75 45 300

HF 12 – 207 720 1 140 1 1.875 0.75 100.75 45.5 301

HF 23 208 159 1 – 140 2 2.125 0.75 112.0 35.75 301

HF 24 208 259 1 – 142 2 2 0.75 105.0 44.5 296

Availability depending on pharmaceutical product registration.

Type/Art. No. Composition of the ready-to-use solution in g/L:

Name 2 × 2 × Sodium Calcium Magnesium Glucose

4.5 L 5.0 L Sodium lactate Sodium Potassium chloride chloride mono- Glucose

chloride solution lactate chloride • 2 H2O • 6 H2O hydrate (waterfree)

HF 11 207 659 1 – 5.552 10.09 5.045 0.0746 0.2389 0.1525 2.154 1.9581

HF 12 – 207 720 1 5.52 10.2 5.1 0.0746 0.2756 0.1525 2.154 1.96

HF 23 208 159 1 – 6.09 8.02 4.01 0.1492 0.3124 0.1525 1.65 1.5

HF 24 208 259 1 – 5.698 9.98 4.99 0.1492 0.294 0.1525 – –

Number of units per pallet: 112 Other constituents: water for injections, hydrochloric acid, sodium hydroxide

56 boxes, each containing two bags.

SolutionsLactate-buffered haemofiltration solutions

Page 20: Sjukvård | Njur | Dialys - Fresenius Medical Care

20 Product Range – 01. 2010 Technical changes reserved

Temporary dialysis catheters

High flow double lumen catheter

• Double lumen shaft geometry in combination

with large inlet and outlet ports at the catheter tip

ensure a low flow resistance also at high blood

flows

• Soft catheter tip – minimises the risk of vascular

lesions upon catheter placement

• Excellent kinking stability

• Optimal range of application: blood flows between

150 mL/min and 400 mL/min

Standard double lumen catheter

• Contralaterally arranged inlet and outlet ports

reduce recirculation

• Optimal range of application: blood flows up to

200 mL/min

• Soft catheter tip – minimises the risk of vascular

lesions upon catheter placement

High flow double lumen catheter sets*

Type Size and length Article No.

TH1415 14.5 F × 150 mm 507 780 1

TH1417 14.5 F × 175 mm 507 782 1

TH1420 14.5 F × 200 mm 507 783 1

TH1424 14.5 F × 240 mm 507 784 1

Double lumen catheter sets*

Type Size and length Article No.

TD1115 11 F × 150 mm 502 877 1

TD1117 11 F × 175 mm 502 874 1

TD1120 11 F × 200 mm 502 878 1

Fresenius Medical Care has developed temporary dialy-

sis catheters specifically for the use in acute therapies.

They ensure a rapid and safe central venous vascular

access via the jugular, subclavian or femoral vein.

* Included accessories: Seldinger puncture cannula (17 G × 70 mm), guide wire (0.95 × 700 mm), step dilatator, injection closure caps, CathClip

Page 21: Sjukvård | Njur | Dialys - Fresenius Medical Care

21Technical changes reserved Product Range – 01. 2010

Disposables and accessories

Waste bags

Type Description Connection Units per box Art. No.

Waste bag 2000 mL Waste bag with female Luer-Lock connector 100 501 509 1

PF waste bag 5000 mL Waste bag with male Luer-Lock connector for single use 50 501 510 1

Filtrate bag 10 L Filtrate collection bag with draining cock, 40 502 901 1

male Luer-Lock connector

Filtrate bag 10 L Filtrate collection bag with male Luer-Lock, 40 502 903 1

Single use single use

Accessories

Type Description Connection Units per box Art. No.

Scissor clamp For clamping lines 5 284 024 1

Freka-Flex Infusion set Infusion set with roller clamp and drip 150 288 901 1

chamber male Luer-lock

Pressure monitor line Pressure monitor line with filter, 100 501 463 1

connector female/male Luer-Lock, length 30 cm

PF-Adapter HF female/ Connection of infusion sets to HF tubing 100 501 474 1

Luer-Lock female

Adapter Connector 2 male Luer-Lock 100 501 477 1

Luer-Lock male

Adapter Connector 2 female Luer-Lock 100 501 480 1

Luer-Lock female

Filtrate adapter Luer-Lock female CVVH/D adapter 100 501 491 1

to the filtrate outlet of a dialyser

Transducer Protector Pressure filter, connector male/female Luer-Lock 100 501 591 1

Spike female Luer-Lock/Spike 100 501 592 1

Vented Spike female Luer-Lock/Spike (vented) 100 F0000520

HF female/ Connection of bags with septum to 100 501 635 1

spike adapter HF tubing system

Adapter HF female/ Connection of 100 501 689 1

Luer-Lock male rinsing solution to HF tubing

Pressure measurement Pressure monitor line with filter, 200 501 915 1

line 60 cm connector male/female Luer-Lock, length 60 cm,

for arterial pressure measurement

SN-adapter Y-adapter, 100 502 785 1

2 × female Luer-Lock/1 × male Luer-Lock

Adapter 2 × HF female / To connect 4 HF bags to HF tubings 30 504 613 1

4 × HF male

Adapter Luer-Lock female/ To connect 6 HF solutions to a substituate 30 504 602 1

6 × HF male (FSG102) system

Check valve Check valve male Luer-Lock/ 100 850 280 2

female Luer-Lock

Heparin syringe 50 mL Fresenius Injectomat syringe, latex-free, male Luer-Lock 100 900 071 1

Heparin syringe 50 mL Fresenius P-syringe, latex-free, male Luer-Lock 100 900 076 1

Page 22: Sjukvård | Njur | Dialys - Fresenius Medical Care

22 Product Range – 01. 2010 Technical changes reserved

Order list

Hospital/Dept.

Title/Name

Street

Country/Postal code/City

Customer No.

Art. No. Article Amount Price

Page 23: Sjukvård | Njur | Dialys - Fresenius Medical Care

23Technical changes reserved Product Range – 01. 2010

Page 24: Sjukvård | Njur | Dialys - Fresenius Medical Care

Headoffice: FreseniusMedicalCareDeutschlandGmbH·61346BadHomburgv.d.H.·Germany·Phone:+49(0)6172-609-0·Fax:+49(0)6172-609-2191

www.fmc-ag.com

732

656

1/8

GB

(1 P

UR

-xx

01.1

0)

© C

opyr

ight

201

0 Fr

esen

ius

Med

ical

Car

e D

euts

chla

nd G

mbH

· T

echn

ical

cha

nges

rese

rved